Tevogen Inc. Common Stock (TVGN)

About TVGN

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune s…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

18

Website

tevogen.com/

Fundamentals

1-day range

$6.62$6.89

Market cap

$45.04M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-6.79

Dividend yield

—

Beta

0.25

Avg. volume

17.8K

Tevogen Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• TVGN

  Tevogen Inc. Common Stock

  $6.89

  ▲ 2.07%
  Market cap $45.04MP/E —
  $3.64$49.5
• EXOZ

  eXoZymes Inc. Common Stock

  $7.17

  ▼ 0.10%
  Market cap $47.57MP/E —
  $4.35$18.4
• TIL

  Instil Bio Inc. Common Stock

  $7.58

  ▼ 3.56%
  Market cap $48.97MP/E —
  $5.67$33.83
• DYAI

  Dyadic International Inc. Common Stock

  $0.6207

  ▼ 3.02%
  Market cap $38.63MP/E —
  $0.6197$1.6
• ELUT

  Elutia Inc. Class A Common Stock

  $0.885

  ▲ 0.57%
  Market cap $38.32MP/E 0.75
  $0.5$2.4
• INKT

  MiNK Therapeutics Inc. Common Stock

  $11.43

  ▼ 2.16%
  Market cap $53.26MP/E —
  $8.48$16.98
• SCLX

  Scilex Holding Company Common Stock

  $5.42

  ▼ 2.69%
  Market cap $55.70MP/E —
  $4.2$34.27

P/E shows — for peers not currently carrying a live signal of their own.

• Sordillo Victor J. · July 10, 2026 · Grant

  40.0K
• Saadi Ryan H. · July 10, 2026 · Grant

  1.22M
• Patton Curtis L. · July 10, 2026 · Grant

  40.0K
• Goh Keow Lin · July 10, 2026 · Grant

  40.0K
• Feike Jeffrey L. · July 10, 2026 · Grant

  40.0K
• Desai Kirti · July 10, 2026 · Grant

  40.0K
• PODLOGAR SUSAN M · July 10, 2026 · Grant

  40.0K
• Flomenberg Neal · March 13, 2026 · Sale

  501 @ $6.4
• Flomenberg Neal · March 11, 2026 · Sale

  452 @ $7.26
• Flomenberg Neal · March 10, 2026 · Sale

  19 @ $7.75

Institutional Ownership

March 31, 2026

Total shares held

129.5K

Total value held

$585.4K

Institutional holders

27